Expression of PD-L1 and BRCA1 in Triple-Negative Breast Cancer Patients and Relationship with Clinicopathological Characteristics.

Huang X, Wang X, Qian H, Jin X, Jiang G

Open source

DOI
10.1155/2021/5314016
Published
2021
Container
Evidence-based complementary and alternative medicine : eCAM
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2021/5314016,
  title = {Expression of PD-L1 and BRCA1 in Triple-Negative Breast Cancer Patients and Relationship with Clinicopathological Characteristics.},
  author = {Huang X and Wang X and Qian H and Jin X and Jiang G},
  year = {2021},
  journal = {Evidence-based complementary and alternative medicine : eCAM},
  doi = {10.1155/2021/5314016},
  url = {https://doi.org/10.1155/2021/5314016}
}

RIS

TY  - JOUR
TI  - Expression of PD-L1 and BRCA1 in Triple-Negative Breast Cancer Patients and Relationship with Clinicopathological Characteristics.
AU  - Huang X
AU  - Wang X
AU  - Qian H
AU  - Jin X
AU  - Jiang G
PY  - 2021
JO  - Evidence-based complementary and alternative medicine : eCAM
DO  - 10.1155/2021/5314016
UR  - https://doi.org/10.1155/2021/5314016
ER  - 

APA

X, H., X, W., H, Q., X, J., & G, J. (2021). Expression of PD-L1 and BRCA1 in Triple-Negative Breast Cancer Patients and Relationship with Clinicopathological Characteristics.. Evidence-based complementary and alternative medicine : eCAM. https://doi.org/10.1155/2021/5314016

Source records